Albert D. Dyrness's most recent trade in Sonnet BioTherapeutics Holdings Inc was a trade of 373 Common Stock done . Disclosure was reported to the exchange on Dec. 11, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Sonnet BioTherapeutics Hol... | D. Albert Dyrness | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2023 | 373 | 537 | - | - | Common Stock | |
Sonnet BioTherapeutics Hol... | Albert D. Dyrness | Director | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 30 May 2023 | 23,255 | 28,962 | - | 0.5 | 10,883 | Common Stock |
Sonnet BioTherapeutics Hol... | Albert D. Dyrness | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2022 | 3,770 | 30,893 | - | - | Common Stock | |
Sonnet BioTherapeutics Hol... | Albert D. Dyrness | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 8,005 | 12,971 | - | 0 | Common Stock | |
Sonnet BioTherapeutics Hol... | Albert D. Dyrness | None | Purchase of securities on an exchange or from another person at price $ 4.01 per share. | 11 Jun 2020 | 2,409 | 4,966 | - | 4.0 | 9,660 | Common Stock |